B. Riley Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

B. Riley Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$278	Sell	8,844 -7,708	-47%	-$270K	﹤0.01%	551
2022 Q1	$868K	Buy	16,552 +6,959	+73%	+$332K	0.07%	230
2021 Q4	$587K	Sell	9,593 -258	-3%	-$17.8K	0.04%	310
2021 Q3	$736K	Sell	9,851 -8,296	-46%	-$696K	0.06%	266
2021 Q2	$1.96M	Buy	18,147 +550	+3%	+$46.8K	0.22%	105
2021 Q1	$1.79M	Buy	+17,597	New	+$1.75M	0.21%	104

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

B. Riley Wealth Management's ARKG Position: Q2 2022 in Review

B. Riley Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 47% in Q2 2022, selling an estimated $270K and leaving 8,844 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #551.

B. Riley Wealth Management first reported a position in ARKG in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.96M in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

B. Riley Wealth Management held 8,844 shares of ARK Genomic Revolution ETF worth $278 as of Q2 2022.
B. Riley Wealth Management sold 7,708 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $270K.
ARK Genomic Revolution ETF made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #551 holding.
B. Riley Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 6 quarters since.
B. Riley Wealth Management's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.